143 related articles for article (PubMed ID: 11792059)
1. Hepatitis C virus: immunosuppression by complement regulatory pathway.
Yao ZQ; Ray S; Eisen-Vandervelde A; Waggoner S; Hahn YS
Viral Immunol; 2001; 14(4):277-95. PubMed ID: 11792059
[TBL] [Abstract][Full Text] [Related]
2. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
Kittlesen DJ; Chianese-Bullock KA; Yao ZQ; Braciale TJ; Hahn YS
J Clin Invest; 2000 Nov; 106(10):1239-49. PubMed ID: 11086025
[TBL] [Abstract][Full Text] [Related]
3. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
4. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
Yao ZQ; King E; Prayther D; Yin D; Moorman J
Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
[TBL] [Abstract][Full Text] [Related]
5. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.
Yao ZQ; Eisen-Vandervelde A; Waggoner SN; Cale EM; Hahn YS
J Virol; 2004 Jun; 78(12):6409-19. PubMed ID: 15163734
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway.
Yao ZQ; Nguyen DT; Hiotellis AI; Hahn YS
J Immunol; 2001 Nov; 167(9):5264-72. PubMed ID: 11673541
[TBL] [Abstract][Full Text] [Related]
7. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
Large MK; Kittlesen DJ; Hahn YS
J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of HCV-mediated immune dysregulation.
Eisen-Vandervelde AL; Yao ZQ; Hahn YS
Clin Immunol; 2004 Apr; 111(1):16-21. PubMed ID: 15093547
[TBL] [Abstract][Full Text] [Related]
9. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.
Yao ZQ; Waggoner SN; Cruise MW; Hall C; Xie X; Oldach DW; Hahn YS
J Virol; 2005 Dec; 79(24):15417-29. PubMed ID: 16306613
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model.
Soguero C; Joo M; Chianese-Bullock KA; Nguyen DT; Tung K; Hahn YS
J Virol; 2002 Sep; 76(18):9345-54. PubMed ID: 12186917
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.
Chung H; Watanabe T; Kudo M; Chiba T
J Infect Dis; 2010 Sep; 202(6):853-61. PubMed ID: 20677943
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.
Yao ZQ; Prayther D; Trabue C; Dong ZP; Moorman J
Immunology; 2008 Oct; 125(2):197-207. PubMed ID: 18397267
[TBL] [Abstract][Full Text] [Related]
13. HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1.
Yao ZQ; Eisen-Vandervelde A; Ray S; Hahn YS
Virology; 2003 Sep; 314(1):271-82. PubMed ID: 14517080
[TBL] [Abstract][Full Text] [Related]
14. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
15. Immune modulation by the hepatitis C virus core protein.
Fernández-Ponce C; Dominguez-Villar M; Muñoz-Miranda JP; Arbulo-Echevarria MM; Litrán R; Aguado E; García-Cozar F
J Viral Hepat; 2017 May; 24(5):350-356. PubMed ID: 28092420
[TBL] [Abstract][Full Text] [Related]
16. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the hepatitis C virus and the immune system.
Rehermann B
Semin Liver Dis; 2000; 20(2):127-41. PubMed ID: 10946419
[TBL] [Abstract][Full Text] [Related]
18. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.
Cummings KL; Rosen HR; Hahn YS
Clin Immunol; 2009 Sep; 132(3):401-11. PubMed ID: 19473882
[TBL] [Abstract][Full Text] [Related]
19. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
Landi A; Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
J Viral Hepat; 2011 Oct; 18(10):700-13. PubMed ID: 20701679
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
